CAMP4 THERAPEUTICS CORPORATION

Stock Chart, Company Information, and Scan Results

$5.44(as of Aug 14, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

CAMP4 THERAPEUTICS CORPORATION Company Information, Fundamentals, and Technical Indicators

Stock Price$5.44
Ticker SymbolCAMP
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees48
CountyUSA
Market Cap$341.4M
EBIDTA-50.3M
10-Day Moving Average4.40
P/E Ratio0.00
20-Day Moving Average3.84
Forward P/E Ratio0.00
50-Day Moving Average4.06
Earnings per Share-2.35
200-Day Moving Average4.46
Profit Margin0.00%
RSI71.53
Shares Outstanding62.8M
ATR0.43
52-Week High7.75
Volume415,200
52-Week Low1.41
Most Recent Support Level4.12
Book Value0.0M
Most Recent Resistance Level4.63
P/B Ratio0.00
Upper Keltner4.82
P/S Ratio0.00
Lower Keltner2.86
Debt-to-Equity Ratio0.00
Next Earnings DateUnknown
Cash Surplus0.0M
Next Ex-Dividend DateUnknown

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

CAMP4 THERAPEUTICS CORPORATION In Our Stock Scanner

As of Aug 16, 2026
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.